ARC DETECTION FOR AMPLIFICATION BASED GENETIC TYPING

Information

  • Research Project
  • 2030097
  • ApplicationId
    2030097
  • Core Project Number
    R43HL056531
  • Full Project Number
    1R43HL056531-01A1
  • Serial Number
    56531
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/15/1997 - 26 years ago
  • Project End Date
    6/14/1998 - 26 years ago
  • Program Officer Name
  • Budget Start Date
    9/15/1997 - 26 years ago
  • Budget End Date
    6/14/1998 - 26 years ago
  • Fiscal Year
    1997
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    9/15/1997 - 26 years ago

ARC DETECTION FOR AMPLIFICATION BASED GENETIC TYPING

The overall objective of this proposal is to provide a fast and reliable automated method for amplification-based genetic typing of point mutations and allelic single-base changes. The proposed method called ARCTM detection, is designed for analysis of highly polymorphic DNA targets that can be amplified by the polymerase chain reaction (PCR). The method can simultaneously type hundreds of nucleotide positions using the amplified products from a single PCR reaction. The ARCTM process relies on polymerase extension of allele-specific primer pairs that have been immobilized on a solid support. ARCTM detection will provide faster and more reliable typing results than allele-specific hybridization, with less technician labor, and should have broad applications in HLA typing, diagnosis of genetic disease, infectious disease diagnostics, forensics, genetic mapping and mutation analysis. In phase I, the feasibility of the proposed method will be tested by constructing a prototype, twelve-assay, multiplex ARC detector for typing all HLA-DQA1 alleles using a single amplification reaction. PROPOSED COMMERCIAL APPLICATIONS ARC TM detection will have broad applications in HLA typing, blood and plasma screening, genetic disease diagnosis, infectious disease diagnostics, cancer diagnostics, and DNA-based forensics. Our initial products will be HLA typing systems for the tissue-typing and forensic testing industries.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    839
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG2
  • Study Section Name
  • Organization Name
    MOSAIC TECHNOLOGIES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    WALTHAM
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02451
  • Organization District
    UNITED STATES